Sexual Infantilism: Clinical Trials

10 trials for Sexual Infantilism, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 2 active not recruiting, 1 enrolling by invitation, 1 withdrawn. 10 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 210Completed 6, Active not recruiting 2, Enrolling by invitation 1, Withdrawn 1
Phase 12Active not recruiting 1, Completed 1

Follow Sexual Infantilism: new trials by email Literature Review of Sexual Infantilism trials Research Report on Sexual Infantilism

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Long-Term Study of Bivamelagon in Participants With Hypothalamic Obesity (HO)
Bivamelagon - Hypothalamic Obesity
Phase 2Enrolling by invitationRhythm Pharmaceuticals, Inc.252025-11-102026-02-10
Efficacy and Safety of Phentermine/Topiramate in Youth With Hypothalamic Obesity
Phentermine / Topiramate Extended Release Oral Capsule [Qsymia], Placebo - Hypothalamic Obesity, Hypothalamic Tumor
Phase 2Active not recruitingSeattle Children's Hospital242025-03-012026-10-16
A Study to Assess Efficacy and Safety of LB54640 in Patients With Hypothalamic Obesity
Bivamelagon, Placebo - Hypothalamic Obesity
Phase 2CompletedRhythm Pharmaceuticals, Inc.282024-07-112026-10-30
A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment
Part A: RM-718 or placebo (matched to specific RM-718 dose cohort), Part B: RM-718 or placebo (matched to specific RM-718 dose cohort), Part C: RM-718 - Hypothalamic Obesity, Prader-Willi Syndrome
Phase 1 / Phase 2Active not recruitingRhythm Pharmaceuticals, Inc.1112024-03-052026-10-09
Study of Tesomet With Open-label Extension in Subjects With Hypothalamic Obesity (HO)
Placebo, Tesomet - Hypothalamic Obesity
Phase 2WithdrawnSaniona2021-11-112022-12-13
Open-Label Study of Setmelanotide in Hypothalamic Obesity
Setmelanotide - Hypothalamic Obesity
Phase 2CompletedRhythm Pharmaceuticals, Inc.182021-06-072025-02-07
Intranasal Oxytocin in Hypothalamic Obesity
Syntocinon, Placebo (for Syntocinon) - Craniopharyngioma, Hypothalamic Obesity
Phase 2CompletedShana McCormack, MD182016-10-012022-10-05
Weight Loss Study for Patients With Obesity Due to Craniopharyngioma or Other Brain Tumor
Exenatide - Obesity, Overweight
Phase 2CompletedVanderbilt University Medical Center102012-06-012017-03-03
Effects of Exenatide on Hypothalamic Obesity
Exenatide - Hypothalamic Obesity
Phase 1 / Phase 2CompletedChildren's Hospitals and Clinics of Minnesota192010-01-012019-10-08
Hypothalamic Obesity Following Craniopharyngioma Surgery: A Pilot Trial of Combined Metformin and Diazoxide Therapy
Diazoxide, Metformin - Hypothalamic Obesity
Phase 2CompletedThe Hospital for Sick Children92006-05-012017-11-17

Narrower conditions

Craniopharyngioma (4)  ·  Obesity (2)  ·  Hypothalamic Neoplasms (1)  ·  Overweight (1)  ·  Prader-Willi Syndrome (1)

Broader conditions

Congenital Abnormalities (10)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (10)  ·  Disorders of Sex Development (10)  ·  Endocrine System Diseases (10)  ·  Female Urogenital Diseases (10)  ·  Female Urogenital Diseases and Pregnancy Complications (10)  ·  Gonadal Disorders (10)  ·  Gonadal Dysgenesis (10)  ·  Hypogonadism (10)  ·  Male Urogenital Diseases (10)  ·  Urogenital Abnormalities (10)  ·  Urogenital Diseases (10)  ·  Neoplasms (4)  ·  Neoplasms by Histologic Type (4)  ·  Neoplasms, Germ Cell and Embryonal (4)

Interventions

Exenatide (2)  ·  Diazoxide (1)  ·  Metformin (1)  ·  Metoprolol (1)  ·  Oxytocin (1)  ·  Phentermine (1)  ·  Qsymia (1)  ·  Tesofensine (1)  ·  setmelanotide (1)

Sponsors

Rhythm Pharmaceuticals, Inc. (4)  ·  Children's Hospitals and Clinics of Minnesota (1)  ·  Saniona (1)  ·  Seattle Children's Hospital (1)  ·  Shana McCormack, MD (1)  ·  The Hospital for Sick Children (1)  ·  Vanderbilt University Medical Center (1)

Countries

United States (9)  ·  United Kingdom (2)  ·  Canada (1)

Top investigators

David Meeker, MD (3)  ·  Shana E McCormack, MD (2)  ·  Ashley Shoemaker, M.D. (1)  ·  Christian L Roth, MD (1)  ·  David Meeker (1)  ·  Jill Hamilton, MD (1)  ·  M. Jennifer Abuzzahab, MD (1)  ·  Sophie Guillaume, MS (1)

Results publications

PMID 27133664